Leptin increases striatal dopamine D2 receptor binding in leptin‐deficient obese (ob/ob) mice
- 19 February 2010
- Vol. 64 (7) , 503-510
- https://doi.org/10.1002/syn.20755
Abstract
Peripheral and central leptin administration have been shown to mediate central dopamine (DA) signaling. Leptin‐receptor deficient rodents show decreased DA D2 receptor (D2R) binding in striatum and unique DA profiles compared to controls. Leptin‐deficient mice show increased DA activity in reward‐related brain regions. The objective of this study was to examine whether basal D2R‐binding differences contribute to the phenotypic behaviors of leptin‐deficient ob/ob mice, and whether D2R binding is altered in response to peripheral leptin treatment in these mice. Leptin decreased body weight, food intake, and plasma insulin concentration in ob/ob mice but not in wild‐type mice. Basal striatal D2R binding (measured with autoradiography [3H] spiperone) did not differ between ob/ob and wild‐type mice but the response to leptin did. In wild‐type mice, leptin decreased striatal D2R binding, whereas, in ob/ob mice, leptin increased D2R binding. Our findings provide further evidence that leptin modulates D2R expression in striatum and that these effects are genotype/phenotype dependent. Synapse 64:503–510, 2010.Keywords
This publication has 44 references indexed in Scilit:
- Bromocriptine Administration Reduces Hyperphagia and Adiposity and Differentially Affects Dopamine D2 Receptor and Transporter Binding in Leptin-Receptor-Deficient Zucker Rats and Rats with Diet-Induced ObesityNeuroendocrinology, 2008
- Relation Between Obesity and Blunted Striatal Response to Food Is Moderated by Taq IA A1 AlleleScience, 2008
- Evidence for defective mesolimbic dopamine exocytosis in obesity‐prone ratsThe FASEB Journal, 2008
- Hypoinsulinemia Regulates Amphetamine-Induced Reverse Transport of DopaminePLoS Biology, 2007
- A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placeboBMC Endocrine Disorders, 2007
- Bromocriptine-Induced Hyperglycemia in Nonobese Diabetic Mice: Kinetics and Mechanisms of ActionThe Review of Diabetic Studies, 2007
- Role of brain dopamine in food reward and reinforcementPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2006
- Cerebrospinal Fluid and Plasma Leptin Measurements: Covariability with Dopamine and Cortisol in Fasting HumansJournal of Clinical Endocrinology & Metabolism, 1999
- Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabeticsCellular and Molecular Life Sciences, 1992
- Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatmentLife Sciences, 1988